SCHEMBL7983187

SCHEMBL7983187

CC(=O)N(C[C@H](NC(=O)OCc1ccccc1)C(=O)O)N1C(=O)N[C@](C)(c2ccc(C(=N)N)cc2)C1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 8/20 0.44
ITGA2B P08514 7/20 0.44
PLAU P00749 4/20 0.43
F2 P00734 3/20 0.43
PLG P00747 3/20 0.43
PLAT P00750 3/20 0.43
KLK8 O60259 2/20 0.43
F10 P00742 2/20 0.43
KLK4 Q9Y5K2 2/20 0.43
KLK1 P06870 1/20 0.40
KLK2 P20151 1/20 0.40
PPARG P37231 1/20 0.40
PPARA Q07869 1/20 0.40
IDO1 P14902 1/20 0.39
TDO2 P48775 1/20 0.39
ITGAV P06756 4/20 0.38
CTSL P07711 2/20 0.37
CTSB P07858 2/20 0.37
CTSS P25774 2/20 0.37
CTSK P43235 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8492406 0.99 ITGB3 (0.44) ITGB3ITGA2BPLAUF2PLG
Hydrochloric Acid SCHEMBL7981048 0.91 ITGB3 (0.41) ITGB3ITGA2BPLAUF2PLG
Hydrochloric Acid SCHEMBL7981050 0.91 ITGB3 (0.41) ITGB3ITGA2BPLAUF2PLG
SCHEMBL7969566 0.81 ITGB3 (0.44) ITGB3ITGA2BF2
SCHEMBL7980895 0.80 PLG (0.45) ITGB3ITGA2BPLAUF2PLG
SCHEMBL7983192 0.79 ITGB3 (0.58) ITGB3ITGA2BITGAVITGA4ITGB7
SCHEMBL7983179 0.79 ITGB3 (0.58) ITGB3ITGA2BITGAVITGA4ITGB7
Hydrochloric Acid SCHEMBL8492400 0.79 ITGB3 (0.57) ITGB3ITGA2BITGAVITGA4ITGB7
Hydrochloric Acid SCHEMBL8492408 0.79 ITGB3 (0.57) ITGB3ITGA2BITGAVITGA4ITGB7
Hydrochloric Acid SCHEMBL7983746 0.78 ITGB3 (0.44) ITGB3ITGA2BALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6191282-B1 DERIVATIVES OF 5-MEMBERED NITROGEN CONTAINING HETEROCYCLIC RING IS USED AS ANTICARCINOGENIC AGENT AND ANTICOAGULANT HOECHST MARION ROUSSEL (DE) 2001-02-20 US disclosed
US-5981492-A ADMINISTERED TO THE PATIENT TO INHIBIT THROMBOCYTE AGGREGATION, THE METASTASIZATION OF CARCINOMA CELLS, THE BINDING OF OSTEOCLASTS TO THE BONE SURFACE, OR FOR THE TREATMENT OF THROMBOSES HOECHST AKTIENGESELLSCHAFT (DE) 1999-11-09 US disclosed